Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares OutstandingShort-Term Debt repayments
Ratios

Cue Biopharma (CUE) Accumulated Depreciation & Amortization (2017 - 2025)

Historic Accumulated Depreciation & Amortization for Cue Biopharma (CUE) over the last 9 years, with Q3 2025 value amounting to $3.6 million.

  • Cue Biopharma's Accumulated Depreciation & Amortization fell 776.92% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year decrease of 776.92%. This contributed to the annual value of $3.7 million for FY2024, which is 176.99% up from last year.
  • Latest data reveals that Cue Biopharma reported Accumulated Depreciation & Amortization of $3.6 million as of Q3 2025, which was down 776.92% from $3.9 million recorded in Q2 2025.
  • Over the past 5 years, Cue Biopharma's Accumulated Depreciation & Amortization peaked at $4.6 million during Q3 2023, and registered a low of $3.0 million during Q2 2021.
  • For the 5-year period, Cue Biopharma's Accumulated Depreciation & Amortization averaged around $3.8 million, with its median value being $3.8 million (2025).
  • As far as peak fluctuations go, Cue Biopharma's Accumulated Depreciation & Amortization soared by 3626.13% in 2021, and later plummeted by 1585.76% in 2024.
  • Cue Biopharma's Accumulated Depreciation & Amortization (Quarter) stood at $3.4 million in 2021, then rose by 23.18% to $4.2 million in 2022, then fell by 14.76% to $3.6 million in 2023, then grew by 1.77% to $3.7 million in 2024, then dropped by 2.26% to $3.6 million in 2025.
  • Its Accumulated Depreciation & Amortization stands at $3.6 million for Q3 2025, versus $3.9 million for Q2 2025 and $3.8 million for Q1 2025.